Verheul HM - Search Results

1

Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas.

Verheul HM, Hoekman K, Lupu F, Broxterman HJ, van der Valk P, Kakkar AK, Pinedo HM. Verheul HM, et al. Clin Cancer Res. 2000 Jan;6(1):166-71. Clin Cancer Res. 2000. PMID: 10656446

2

Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer.

Honkoop AH, Pinedo HM, De Jong JS, Verheul HM, Linn SC, Hoekman K, Wagstaff J, van Diest PJ. Honkoop AH, et al. Among authors: verheul hm. Am J Clin Pathol. 1997 Feb;107(2):211-8. doi: 10.1093/ajcp/107.2.211. Am J Clin Pathol. 1997. PMID: 9024070

3

Platelet: transporter of vascular endothelial growth factor.

Verheul HM, Hoekman K, Luykx-de Bakker S, Eekman CA, Folman CC, Broxterman HJ, Pinedo HM. Verheul HM, et al. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2187-90. Clin Cancer Res. 1997. PMID: 9815613

4

A patient with adrenocortical carcinoma: characterization of its biological activity and drug resistance profile.

Feller N, Hoekman K, Kuiper CM, Linn SC, Verheul HM, Wolthers BG, Popp-Snijders C, Pinedo HM. Feller N, et al. Among authors: verheul hm. Clin Cancer Res. 1997 Mar;3(3):389-94. Clin Cancer Res. 1997. PMID: 9815696

5

Involvement of platelets in tumour angiogenesis?

Pinedo HM, Verheul HM, D'Amato RJ, Folkman J. Pinedo HM, et al. Among authors: verheul hm. Lancet. 1998 Nov 28;352(9142):1775-7. doi: 10.1016/s0140-6736(98)05095-8. Lancet. 1998. PMID: 9848370

6

Prolonged neoadjuvant treatment in locally advanced tumours: a novel concept based on biological considerations.

Luykx-de Bakker SA, Verheul HM, de Gruijl TD, Pinedo HM. Luykx-de Bakker SA, et al. Among authors: verheul hm. Ann Oncol. 1999 Feb;10(2):155-60. doi: 10.1023/a:1008360314669. Ann Oncol. 1999. PMID: 10093683 Free article. Review.

7

[Inhibition of tumor angiogenesis as a cancer treatment].

Verheul HM, Bom JB, Hoekman K, Pinedo HM. Verheul HM, et al. Ned Tijdschr Geneeskd. 1999 Jul 24;143(30):1549-55. Ned Tijdschr Geneeskd. 1999. PMID: 10443279 Review. Dutch.

8

Treatment of the Kasabach-Merritt syndrome with pegylated recombinant human megakaryocyte growth and development factor in mice: elevated platelet counts, prolonged survival, and tumor growth inhibition.

Verheul HM, Panigrahy D, Flynn E, Pinedo HM, D'Amato RJ. Verheul HM, et al. Pediatr Res. 1999 Nov;46(5):562-5. doi: 10.1203/00006450-199911000-00012. Pediatr Res. 1999. PMID: 10541319

9

[Coagulation disorders in cancer patients: possible opportunity for therapy].

Bom JB, Verheul HM, Hoekman K, Pinedo HM. Bom JB, et al. Among authors: verheul hm. Ned Tijdschr Geneeskd. 2000 Feb 5;144(6):258-63. Ned Tijdschr Geneeskd. 2000. PMID: 10687017 Review. Dutch.

10

Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formation.

Verheul HM, Hoekman K, Jorna AS, Smit EF, Pinedo HM. Verheul HM, et al. Oncologist. 2000;5 Suppl 1:45-50. doi: 10.1634/theoncologist.5-suppl_1-45. Oncologist. 2000. PMID: 10804091 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters